Blog - Clinical Perspectives

Filler-induced vascular is not a risk. It is a documented, recurring complication that practitioners across all experience levels. A practitioner who has the to hand and has rehearsed the management is in a to act . One who has not is not. The difference in outcome these two can be the difference between resolution and permanent vision loss.

Every prescription has a . Botulinum toxin is no . And yet the between dose, effect, and in practice is rarely with the rigour it deserves — partly because the consequences of under-dosing are rather than immediately . Here is what the evidence says.

Any practitioner who has the same with toxin over a number of years will have the pattern. Early in treatment, last three to four months. Over time, the . The effect is real, consistent, and well recognised in clinical practice. What deserves more is why it — and one of the mechanisms has been sitting in plain sight for twenty years.

Professor Andy is not a . He has never a patient. But for thirty years he has done something the rarely — to its most widely used treatment and omnisculpt – toning/sculpting challenging the myths that have around it. Here is what he found.

Over 140 dermal are for use in the European market. The United States has fewer than 25 FDA-approved . That disparity is not a reflection of greater European innovation. It is a of fundamentally different regulatory — and those has genuine clinical implications for every practitioner in UK .

8 cosmetic toxin are worldwide every year. In over three decades of use, the treatment has never caused a single death. In counterfeit and unlicensed use, patients have mechanical ventilation. The is not the molecule. It is that surrounds it.

Zein Obagi spent two years as what he called an "aesthetic detective" before developing the System in 1985 — a physician-dispensed skin transformation protocol that brought tretinoin into practice and established a template the entire subsequent industry has . This is his story.

The patient sits down, for their phone, and turns the screen you. On it is a photograph — a celebrity, an influencer, a encountered on — and the request is clear: I would like to look like this. It is one of the most common moments in practice. It is also one of the most clinically significant — and what happens next matters more than most practitioners acknowledge.

The idea that gut health influences skin health is not new. What is new is the mechanistic of how these connections work — and the growing that the gut microbiome influences not just specific skin diseases but skin health, skin ageing, and skin function in a more general and way.

The conversation about has been dominated by prevention. What has received less honest clinical attention is what can be done for damage accumulated. The answer is more encouraging than most patients are told — and more than the aesthetic marketing tends to .

 If a asked us to the single with the greatest evidence base for preventing skin ageing, the answer would not be a or a . It would be daily, broad-spectrum, high-factor sun — consistently, without exception, regardless of or season. Everything else in a regimen is built on that .

Aesthetic medicine has historically been uncomfortable with its psychological — presenting itself in purely physical terms as though the motivation behind were irrelevant to the clinical . It is not. The evidence that appropriate treatment improves wellbeing in patients is real. So is the that it cannot resolve deeper psychological . Both to be examined .

The degree of dehydration required to produce visible skin changes is pathological. It represents a fluid deficit that would, in any person, produce thirst long before the skin showed any change. The hand turgor test is a tool for assessing clinically unwell patients — not a guide to the skincare habits of the well.

Microneedling is as a relatively recent innovation. In fact, the concept of using controlled skin injury to collagen production predates most of the treatments that now share its space. The modern was in the mid-1990s by Dr. Fernandes, a South African plastic surgeon, whose clinical have since been characterised in considerable detail. Here is an honest of what the evidence actually says.

Before examining any ingredient on its own terms, there is a prior question the consistently fails to ask loudly enough. Does it penetrate the skin barrier in a biologically active form, in sufficient concentration, to reach the tissue where it is supposed to act? That is the lens through which everything that follows should be read.

No topical ingredient has been studied as thoroughly, over as long a period, or with as consistently results as retinoic acid and its derivatives. When a patient asks whether a new might be as effective as their retinoid, the honest answer almost always begins with an acknowledgement that nothing has had the time, the research investment, or the clinical to make that comparison confidently.

The phrase "skin barrier" has entered mainstream to the point where it has begun to lose its meaning. This piece is about the in precise terms: what structures comprise it, what they do, what causes them to fail, and what the says about restoring them. Understanding it at this level is not merely . It informs every clinical about .

The who has lost significant weight has typically worked hard to do so. The body looks better. And then they look at their face. What they see is not always what they — a face that looks older, more gaunt, more depleted than it did before. This is a and consequence of significant and rapid weight loss. It to be understood clinically with the same seriousness as the weight loss itself.

A subset of consultations feels different from the moment the sits down. She is a barrister, a senior executive, a . Her appearance is not merely something she thinks about in the mirror. It is something presented to the world professionally, assessed in that carry real consequences, and evaluated against a standard that would not apply to a male colleague in an .

The phrase "non-surgical facelift" the outcome of a significant surgical procedure without the recovery, the risk, or the cost that surgery entails. It is, in almost every application, a . This is not an argument against aesthetic treatment. It is an for about what those treatments can and cannot do.

6 Esher Park Avenue
Esher, Surrey KT10 9NP

Tel: ‬
Tel: ‭ ‬

© 2026
The Doctors
Company Ltd
Company no.